Assessments of single biomarkers
Assessments of omic profiles (metabolomics, proteomic, peptidomic) The omic profiles in general population and patients with diabetes will be compared to assess if there are disease specific profiles associated with diease progression or whether common omic profiles exists independent of background population, type of disease, or severity of the disease.
The population will be divided in test and validation cohorts to ensure external validation of the discovered profiles
The omic profiles will be assessed in alreadly collected samples. Different matrices are available and will be used (plasma, serum, urine).